TOR Signaling Pathway in Cardiac Aging and Heart Failure
mechanistic Target of Rapamycin (mTOR) signaling is a key regulator of cellular metabolism, integrating nutrient sensing with cell growth. Over the past two decades, studies on the mTOR pathway have revealed that mTOR complex 1 controls life span, health span, and aging by modulating key cellular pr...
Main Authors: | Nastaran Daneshgar, Peter S. Rabinovitch, Dao-Fu Dai |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/2/168 |
Similar Items
-
mTOR inhibition: a promise for a young heart.
by: Stêfany Bruno De Assis Cau, et al.
Published: (2012-02-01) -
Neuroimaging Biomarkers of mTOR Inhibition on Vascular and Metabolic Functions in Aging Brain and Alzheimer’s Disease
by: Jennifer Lee, et al.
Published: (2018-07-01) -
Inhibition of mTOR prevents ROS production initiated by ethidium bromide-induced mitochondrial DNA depletion.
by: Timothy eNacarelli, et al.
Published: (2014-07-01) -
The mTOR Signalling Pathway in Human Cancer
by: Paula Soares, et al.
Published: (2012-02-01) -
Yes-Associated Protein (Yap) Is Up-Regulated in Heart Failure and Promotes Cardiac Fibroblast Proliferation
by: Maryam Sharifi-Sanjani, et al.
Published: (2021-06-01)